Retractable Technologies is cutting 16% of its workforce to save $2.2 million annually and strengthen domestic production.

A Hawaii doctor who was accused of trying to kill his wife on a cliffside hike has been convicted of attempted manslaughter.

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

The Tennessee Supreme Court has temporarily blocked a lower court’s order that would have let media witnesses view more parts of state-run executions. The high court’s ruling Wednesday comes ...

Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16%. The reduction is expected to save an estimated $2.2 million in annual wages and ...

April 8 (Reuters) - The U.S. Food and Drug Administration has told medical device maker Medline that its syringes used in ...

Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and ...

The U.S. FDA issued a warning letter to Medline Inc. having identified several issues with its Namic brand angiographic control syringes and manifolds used for the intra-arterial or intravenous ...

Medline (MDLN) stock is in focus as the FDA warns the company over issues related to the production of NAMIC Angiographic ...

After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns ...

Sanofi's Sarclisa has played second fiddle to Johnson & Johnson's Darzalex in the treatment of multiple myeloma (MM), but the company hopes a new delivery option could give it more of a leading role.

Syringes, autoinjectors, lancets and infusion sets are among the items now being accepted when packaged securely at Oak Park ...